Company intelligence / Profile preview

OmegaVet

Tampa, Florida, United States

Ownership: Private
Development stage: Other

Overview

OmegaVet is a veterinary pharmaceutical company dedicated to the development and commercialization of innovative therapeutic solutions for companion animals. The company focuses on addressing unmet medical needs in pets, particularly in the areas of chronic pain management, inflammatory diseases, and dermatology. By leveraging advancements in human biotechnology, OmegaVet aims to translate cutting-edge science into safe and effective treatments for dogs and cats. Their current research efforts are centered on novel modalities, including targeted biologics and small molecule inhibitors, to improve the quality of life for aging and diseased pets.

Therapeutic areas: RheumatologyDermatologyNeurology
Modalities: Small moleculeBiologicPeptides
Industry: Veterinary

Beyond the preview

Go deeper on OmegaVet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OmegaVet.

Explore the full profile